Search

everythinglearnresearchcommunity

for

Search:↓

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Trichothiodystrophy hair is structurally abnormal with protein and organization issues.

The paper concludes that recognizing bitemporal alopecia areata is important for early treatment and preventing its progression.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Iodine-deficient diets and antithyroid substances affected rat growth and behavior, but most adapted with positive weight gain.

Thyroid receptor agonists may treat male pattern baldness without harmful side effects.

Targeting immune tolerance issues in Alopecia Areata could restore hair growth and maintain remission.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Toxic Epidermal Necrolysis is a rare, serious skin condition that can affect anyone, is more common in women, and may be linked to genetics, with a 20% mortality rate mainly due to sepsis.

Oral tofacitinib has a moderate success rate and is generally safe for treating hair loss in some patients.

Canine hypothyroidism can be linked to diabetes, requiring thorough testing for proper diagnosis.

A rare case of isolated trichothiodystrophy was identified, marked by brittle hair with low sulfur content.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Parental uveitis increases offspring's risk and severity of autoimmune eye disease.

Autoimmune scalp conditions, especially alopecia areata, are common and can harm self-esteem and quality of life.

A 17-year-old with Netherton syndrome has dry, itchy skin, brittle hair, and high IgE levels, treated with antihistamines and emollients.

The document concludes that ongoing research using animal models is crucial for better understanding and treating Alopecia Areata.

Intradermal testing can better detect corticosteroid allergies than patch testing.

Telogen effluvium is a hair loss condition with acute cases resolving quickly and chronic cases potentially lasting longer, sometimes requiring treatment.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

The document concludes that various hypersensitivity diseases in horses can be diagnosed and treated with methods like immunotherapy and medication, and early aggressive treatment is crucial for severe diseases like equine cutaneous pythiosis.

The most common sign of aging at the gene level is more Ectodysplasin A2 Receptor (EDA2R) being made.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

The enzyme from human skin can cross-link proteins and needs calcium to work.

Women with epilepsy on certain medications might gain weight and have higher thyroid-stimulating hormone levels, but not more polycystic ovarian syndrome.

Non-motor symptoms in myasthenia gravis are common and need early diagnosis for better management.

Severe alopecia areata involves higher levels of certain immune cells, which can be normalized with betamethasone.

Both Th1 and Th2 immune responses are increased in alopecia areata, with Th2 response more strongly linked to how severe the disease is.

Combining triamcinolone acetonide with immunotherapy can help regrow hair in some alopecia totalis patients.